Please use this identifier to cite or link to this item: https://repository.monashhealth.org/monashhealthjspui/handle/1/28977
Title: Delirium.
Authors: Shehabi Y. ;Ely E.W.;Slooter A.J.C.;MacLullich A.M.J.;Cunningham C.;Girard T.D.;Wilson J.E.;Mart M.F.
Institution: (Wilson, Mart, Girard, Ely) Center for Critical Illness, Brain Dysfunction, and Survivorship (CIBS), Vanderbilt University Medical Center, Nashville, TN, United States (Wilson) Department of Psychiatry and Behavioral Sciences, Division of General Psychiatry, Vanderbilt University Medical Center, Nashville, TN, United States (Mart, Ely) Department of Medicine, Division of Allergy, Pulmonary and Critical Care Medicine, Vanderbilt University Medical Center, Nashville, TN, United States (Cunningham) School of Biochemistry & Immunology, Trinity Biomedical Sciences Institute & Trinity College Institute of Neuroscience, Trinity College Dublin, Dublin, Ireland (Shehabi) Monash Health School of Clinical Sciences, Monash University, Melbourne, VIC, Australia (Shehabi) Prince of Wales Clinical School of Medicine, University of New South Wales, Sydney, NSW, Australia (Girard) Clinical Research, Investigation, and Systems Modeling of Acute Illness Center, Department of Critical Care Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States (MacLullich) Edinburgh Delirium Research Group, Geriatric Medicine, Usher Institute, University of Edinburgh, Edinburgh, United Kingdom (Slooter) Department of Intensive Care Medicine and UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands (Ely) Department of Medicine, Division of General Internal Medicine and Public Health, Vanderbilt University Medical Center, Nashville, TN, United States (Ely) Veteran's Affairs TN Valley, Geriatrics Research, Education and Clinical Center (GRECC), Nashville, TN, United States
Issue Date: 24-Dec-2020
Copyright year: 2020
Publisher: Nature Research
Place of publication: United Kingdom
Publication information: Nature Reviews Disease Primers. 6 (1) (no pagination), 2020. Article Number: 90. Date of Publication: December 2020.
Journal: Nature Reviews Disease Primers
Abstract: Delirium, a syndrome characterized by an acute change in attention, awareness and cognition, is caused by a medical condition that cannot be better explained by a pre-existing neurocognitive disorder. Multiple predisposing factors (for example, pre-existing cognitive impairment) and precipitating factors (for example, urinary tract infection) for delirium have been described, with most patients having both types. Because multiple factors are implicated in the aetiology of delirium, there are likely several neurobiological processes that contribute to delirium pathogenesis, including neuroinflammation, brain vascular dysfunction, altered brain metabolism, neurotransmitter imbalance and impaired neuronal network connectivity. The Diagnostic and Statistical Manual of Mental Disorders, 5th edition (DSM-5) is the most commonly used diagnostic system upon which a reference standard diagnosis is made, although many other delirium screening tools have been developed given the impracticality of using the DSM-5 in many settings. Pharmacological treatments for delirium (such as antipsychotic drugs) are not effective, reflecting substantial gaps in our understanding of its pathophysiology. Currently, the best management strategies are multidomain interventions that focus on treating precipitating conditions, medication review, managing distress, mitigating complications and maintaining engagement to environmental issues. The effective implementation of delirium detection, treatment and prevention strategies remains a major challenge for health-care organizations globally.Copyright © 2020, Springer Nature Limited.
DOI: http://monash.idm.oclc.org/login?url=http://dx.doi.org/10.1038/s41572-020-00223-4
PubMed URL: 33184265 [http://www.ncbi.nlm.nih.gov/pubmed/?term=33184265]
ISSN: 2056-676X (electronic)
URI: https://repository.monashhealth.org/monashhealthjspui/handle/1/28977
Type: Review
Subjects: coronavirus disease 2019
degeneration
*delirium/di [Diagnosis]
*delirium/dm [Disease Management]
*delirium/dt [Drug Therapy]
*delirium/ep [Epidemiology]
*delirium/et [Etiology]
*delirium/pc [Prevention]
disease predisposition
disease severity
drug use
DSM-III
encephalitis
energy metabolism
epidemiological data
hospital patient
human
intensive care unit
managed care
neuroanatomy
neuropathology
neuropsychological test
nonhuman
outcome assessment
patient monitoring
prevalence
primary prevention
priority journal
quality of life
stanford proxy test
randomized controlled trial (topic)
review
risk factor
screening test
systematic review (topic)
treatment failure
treatment indication
alpha 2 adrenergic receptor stimulating agent/dt [Drug Therapy]
benzodiazepine derivative
cholinergic receptor/ec [Endogenous Compound]
cholinergic receptor blocking agent
cholinesterase inhibitor/dt [Drug Therapy]
melatonin/dt [Drug Therapy]
neuroleptic agent/dt [Drug Therapy]
neurotransmitter/ec [Endogenous Compound]
scopolamine
4a test
brain metabolism
clinical assessment tool
cognitive defect
encephalitis
energy metabolism
epidemiological data
hospital patient
human
intensive care unit
managed care
neuroanatomy
neuropathology
neuropsychological test
nonhuman
outcome assessment
patient monitoring
prevalence
primary prevention
priority journal
quality of life
randomized controlled trial (topic)
Review
clinical assessment tool
screening test
systematic review (topic)
treatment failure
treatment indication
brain metabolism
risk factor
cognitive defect
coronavirus disease 2019
degeneration
*delirium / *diagnosis / *disease management / *drug therapy / *epidemiology / *etiology / *prevention
disease predisposition
disease severity
drug use
DSM-III
Type of Clinical Study or Trial: Review article (e.g. literature review, narrative review)
Appears in Collections:Articles

Show full item record

Page view(s)

50
checked on Aug 17, 2024

Google ScholarTM

Check


Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.